Literature DB >> 32228281

The multiple sclerosis prodrome: Emerging evidence, challenges, and opportunities.

Helen Tremlett1, Ruth Ann Marrie2.   

Abstract

A prodrome is considered an early set of signs or symptoms indicating the onset of a disease or illness. In multiple sclerosis (MS), the prodromal period is the months or years before our current, classic understanding of "MS symptom onset." Prodromal periods are well recognized in other neurodegenerative conditions and more recently have been shown in MS. In this Viewpoint, we reflect on the emerging evidence surrounding the MS prodrome, including features that may be common across chronic inflammatory and neurodegenerative diseases. Finally, we discuss the implications for future disease prevention in MS.

Entities:  

Keywords:  Multiple sclerosis; diagnosis; disease prevention; pre-symptomatic; pre–multiple sclerosis trait; prodromal phase; prodrome

Year:  2020        PMID: 32228281     DOI: 10.1177/1352458520914844

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  15 in total

1.  The immune signatures of multiple sclerosis: Lessons from twin studies.

Authors:  Pablo Villoslada; Scott S Zamvil
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-14       Impact factor: 11.205

2.  The multiple sclerosis prodrome is just unspecific symptoms in radiologically isolated syndrome patients - Commentary.

Authors:  Naila Makhani
Journal:  Mult Scler       Date:  2021-09-08       Impact factor: 6.312

3.  The MSBase pregnancy, neonatal outcomes, and women's health registry.

Authors:  Vilija G Jokubaitis; Olga Skibina; Raed Alroughani; Ayse Altintas; Helmut Butzkueven; Sara Eichau; Yara Fragoso; Kerstin Hellwig; Stella E Hughes; Louise Rath; Anneke van der Walt; Orla Gray
Journal:  Ther Adv Neurol Disord       Date:  2021-04-12       Impact factor: 6.570

4.  The gut microbiota in pediatric multiple sclerosis and demyelinating syndromes.

Authors:  Helen Tremlett; Feng Zhu; Douglas Arnold; Amit Bar-Or; Charles N Bernstein; Christine Bonner; Jessica D Forbes; Morag Graham; Janace Hart; Natalie C Knox; Ruth Ann Marrie; Ali I Mirza; Julia O'Mahony; Gary Van Domselaar; E Ann Yeh; Yinshan Zhao; Brenda Banwell; Emmanuelle Waubant
Journal:  Ann Clin Transl Neurol       Date:  2021-12-09       Impact factor: 4.511

5.  Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome.

Authors:  Christine Lebrun-Frénay; Fabien Rollot; Lydiane Mondot; Helene Zephir; Celine Louapre; Emmanuelle Le Page; Françoise Durand-Dubief; Pierre Labauge; Caroline Bensa; Eric Thouvenot; David Laplaud; Jerome de Seze; Jonathan Ciron; Bertrand Bourre; Philippe Cabre; Olivier Casez; Aurélie Ruet; Guillaume Mathey; Eric Berger; Thibault Moreau; Abdulatif Al Khedr; Nathalie Derache; Pierre Clavelou; Anne-Marie Guennoc; Alain Créange; Jean-Philippe Neau; Ayman Tourbah; Jean-Philippe Camdessanché; Adil Maarouf; Celine Callier; Patrick Vermersch; Orhun Kantarci; Aksel Siva; Christina Azevedo; Naila Makhani; Mikael Cohen; Daniel Pelletier; Darin Okuda; Sandra Vukusic
Journal:  JAMA Netw Open       Date:  2021-10-01

6.  Association of Infectious Mononucleosis in Childhood and Adolescence With Risk for a Subsequent Multiple Sclerosis Diagnosis Among Siblings.

Authors:  Yin Xu; Ayako Hiyoshi; Kelsi A Smith; Fredrik Piehl; Tomas Olsson; Katja Fall; Scott Montgomery
Journal:  JAMA Netw Open       Date:  2021-10-01

7.  The Multiple Sclerosis Prodrome: Evidence to Action.

Authors:  Helen Tremlett; Kassandra L Munger; Naila Makhani
Journal:  Front Neurol       Date:  2022-01-31       Impact factor: 4.086

Review 8.  The multiple sclerosis prodrome.

Authors:  Naila Makhani; Helen Tremlett
Journal:  Nat Rev Neurol       Date:  2021-06-21       Impact factor: 42.937

9.  Onset Symptom Clusters in Multiple Sclerosis: Characteristics, Comorbidities, and Risk Factors.

Authors:  Vladeta Ajdacic-Gross; Nina Steinemann; Gábor Horváth; Stephanie Rodgers; Marco Kaufmann; Yanhua Xu; Christian P Kamm; Jürg Kesselring; Zina-Mary Manjaly; Chiara Zecca; Pasquale Calabrese; Milo A Puhan; Viktor von Wyl
Journal:  Front Neurol       Date:  2021-07-06       Impact factor: 4.003

10.  Cost-of-Illness Progression Before and After Diagnosis of Multiple Sclerosis: A Nationwide Register-Based Cohort Study in Sweden of People Newly Diagnosed with Multiple Sclerosis and a Population-Based Matched Reference Group.

Authors:  Chantelle Murley; Petter Tinghög; Kristina Alexanderson; Jan Hillert; Emilie Friberg; Korinna Karampampa
Journal:  Pharmacoeconomics       Date:  2021-05-10       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.